Hiive Anthropic Series VII a Series of Hiive Anthropic LLC
Raised
$4M
Investors
34
Min Invest
$0
AltStreet Analysis
·Generated from EDGAR primary sources
Hiive Anthropic Series VII is a pooled investment fund organized as a Delaware series LLC that raised $4.1M from 34 investors under Rule 506(b) and Section 3(c)(1) exemptions. The filing, submitted April 25, 2025, lists no minimum investment and is managed by LLC Sydecar with Brett Sagan as executive officer. This entity is part of the Hiive platform, which operates 69 related EDGAR entities focused on private equity investments.
This 506(b) offering with a $0 stated minimum and 34 investors represents a relatively accessible private equity vehicle, with an average contribution of approximately $121K per investor. The use of Section 3(c)(1) limits the fund to fewer than 100 beneficial owners, consistent with typical SPV structures targeting accredited investors in private company secondaries or direct investments.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
Sydecar LLC
Director · Claymont, DE
Brett Sagan
Executive Officer · Claymont, DE
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. AltStreet analysis (summaries, flags, category context) is generated by Claude from this primary source data and reviewed for accuracy. Platform-provided information (if present) is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. EDGAR data is verified read-only — platforms may request factual corrections for demonstrable inaccuracies by contacting research@altstreet.investments. This page does not constitute investment advice.
